此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Validation of Clinical Decision Support Tool for Acute Stroke Diagnosis (InstaDx)

2018年1月9日 更新者:Dr. Ayeesha Kamran Kamal、Aga Khan University

Validation of Clinical Decision Support Tool Information Technology Application for Stroke Diagnosis

This is a observational validation study. The Stroke Clinical Decision Support Tool ( InstaDx) , an information technology application will be adapted and developed in accordance to evidence based clinical practice guidelines ( Level IA). Neurology Residents will be using the InstaDx CDST to improve their diagnostic accuracy and the findings will be validated against the review of a stroke subject expert. The study hypothesis is that Clinical Decision Support Tool used by neurology residents will have an agreement of >0.77 when compared to Stroke Expert (gold standard) in diagnosing type of ischemic stroke.

研究概览

地位

完全的

详细说明

Overall Objective: To adapt, develop and validate the clinical decision support tool, an information technology application to assist acute stroke diagnosis for use among neurology graduate trainees compared to stroke expert (gold standard).

Specific Aims:

1. To validate the adapted clinical decision support tool, an information technology application to assist acute ischemic stroke diagnosis for use among neurology residents compared to stroke expert (Gold standard) in the adult population presenting at a tertiary care hospital in Pakistan.

The study will be conducted in Emergency department and the Neurology ward at Aga Khan University Hospital. The data collector will enroll the patients meeting the eligibility criteria and providing informed consent. Neurology residents will use the Clinical Decision Support Tool application to assist in acute stroke diagnosis. In the second part, the Stroke Expert will independently assess all diagnosis. The purpose of this would be to validate the Clinical Decision Support Tool application to assist in acute stroke diagnosis.

研究类型

观察性的

注册 (实际的)

210

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Karachi、巴基斯坦、74800
        • Aga Khan University

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

取样方法

非概率样本

研究人群

All men and women greater than or equal to 18 years of age presenting in emergency department with neurological deficit consistent with stroke, fulfilling our eligibility criteria and willing to give voluntary informed consent to participate in the study.

描述

Inclusion Criteria:

  1. Adult men and women, >18 years of age.
  2. Patients admitted with neurological deficit consistent with stroke.
  3. Confirmation of stroke by objective modality of CT scan and MRI.
  4. Consenting to participate in the study.

Exclusion Criteria:

  1. Patients presenting with any type of Haemorrhagic stroke such as Sub-Arachnoid Haemorrhage, Intracerebral Haemorrhage and others.
  2. Stroke due to any iatrogenic causes such as post-surgeries, trauma, or any rare or non atherosclerotic causes eg carotid dissection.
  3. Patients signing LAMA (left against Medical Advice) and leaving undiagnosed

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
Pakistani adult

Men and women aged 18 years or above,presenting with neurological deficit consistent with stroke in the Emergency Department at Aga Khan University Hospital

Consenting to participate in the study

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Validation_Primary Outcome Measure_ Sensitivity
大体时间:Day 1
Sensitivity of InstaDx used by Neurology Residents vs. Diagnosis by Stroke Expert
Day 1
Validation_ Primary Outcome Measure_Specificity
大体时间:Day 1
Specificity of InstaDx used by Neurology Residents vs. Diagnosis by Stroke Expert
Day 1
Validation_Primary Outcome Measure_Positive and Negative Predictive Values
大体时间:Day 1
Predictive Value of InstaDx used by Neurology Residents vs. Diagnosis by Stroke Expert
Day 1

次要结果测量

结果测量
措施说明
大体时间
Acceptability
大体时间:Day 1
Qualitative assessments by focus group discussion will be performed to incorporate user feedback
Day 1

其他结果措施

结果测量
措施说明
大体时间
Implementation Characteristics
大体时间:Day 1
Qualitative assessments by focus group discussion will be performed to evaluate the user feedback to further improve the uptake of the tool.
Day 1

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Ayeesha K Kamal、AKUH
  • 首席研究员:Saadia S Choudhry、AKUH

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2017年2月1日

初级完成 (实际的)

2017年6月30日

研究完成 (实际的)

2017年6月30日

研究注册日期

首次提交

2017年3月3日

首先提交符合 QC 标准的

2017年3月9日

首次发布 (实际的)

2017年3月15日

研究记录更新

最后更新发布 (实际的)

2018年1月10日

上次提交的符合 QC 标准的更新

2018年1月9日

最后验证

2018年1月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

IPD 计划说明

This may be shared on request only.

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅